Universal receptor cell therapy: Began a Phase I/II trial

Cell Genesys Inc. (CEGE), Foster City, Calif. Product: Universal receptor cell therapy, in which patients' CD8+ cytotoxic T cells are engineered to express a construct gene consisting of part of the C...